nodes	percent_of_prediction	percent_of_DWPC	metapath
Olmesartan—SLCO1B3—Methotrexate—psoriatic arthritis	0.247	0.366	CbGbCtD
Olmesartan—ABCC2—Dexamethasone—psoriatic arthritis	0.157	0.233	CbGbCtD
Olmesartan—SLCO1B1—Methotrexate—psoriatic arthritis	0.144	0.213	CbGbCtD
Olmesartan—ABCC2—Methotrexate—psoriatic arthritis	0.126	0.187	CbGbCtD
Olmesartan—Losartan—ACE—psoriatic arthritis	0.00243	1	CrCbGaD
Olmesartan—Tachycardia—Prednisolone—psoriatic arthritis	0.000507	0.00157	CcSEcCtD
Olmesartan—Photosensitivity reaction—Methotrexate—psoriatic arthritis	0.000506	0.00157	CcSEcCtD
Olmesartan—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.000502	0.00155	CcSEcCtD
Olmesartan—Myalgia—Triamcinolone—psoriatic arthritis	0.000498	0.00154	CcSEcCtD
Olmesartan—Pneumonia—Methotrexate—psoriatic arthritis	0.000497	0.00154	CcSEcCtD
Olmesartan—Arthralgia—Methylprednisolone—psoriatic arthritis	0.000497	0.00154	CcSEcCtD
Olmesartan—Myalgia—Methylprednisolone—psoriatic arthritis	0.000497	0.00154	CcSEcCtD
Olmesartan—Anxiety—Methylprednisolone—psoriatic arthritis	0.000495	0.00153	CcSEcCtD
Olmesartan—Infestation NOS—Methotrexate—psoriatic arthritis	0.000494	0.00153	CcSEcCtD
Olmesartan—Infestation—Methotrexate—psoriatic arthritis	0.000494	0.00153	CcSEcCtD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.000494	0.00153	CcSEcCtD
Olmesartan—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.000493	0.00152	CcSEcCtD
Olmesartan—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.000493	0.00152	CcSEcCtD
Olmesartan—Discomfort—Triamcinolone—psoriatic arthritis	0.000492	0.00152	CcSEcCtD
Olmesartan—Discomfort—Methylprednisolone—psoriatic arthritis	0.000491	0.00152	CcSEcCtD
Olmesartan—Renal failure—Methotrexate—psoriatic arthritis	0.000486	0.0015	CcSEcCtD
Olmesartan—Angioedema—Dexamethasone—psoriatic arthritis	0.000485	0.0015	CcSEcCtD
Olmesartan—Angioedema—Betamethasone—psoriatic arthritis	0.000485	0.0015	CcSEcCtD
Olmesartan—Angiopathy—Prednisone—psoriatic arthritis	0.000482	0.00149	CcSEcCtD
Olmesartan—Malaise—Betamethasone—psoriatic arthritis	0.000479	0.00148	CcSEcCtD
Olmesartan—Malaise—Dexamethasone—psoriatic arthritis	0.000479	0.00148	CcSEcCtD
Olmesartan—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.000478	0.00148	CcSEcCtD
Olmesartan—Oedema—Triamcinolone—psoriatic arthritis	0.000478	0.00148	CcSEcCtD
Olmesartan—Vertigo—Betamethasone—psoriatic arthritis	0.000477	0.00147	CcSEcCtD
Olmesartan—Vertigo—Dexamethasone—psoriatic arthritis	0.000477	0.00147	CcSEcCtD
Olmesartan—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.000476	0.00147	CcSEcCtD
Olmesartan—Syncope—Betamethasone—psoriatic arthritis	0.000476	0.00147	CcSEcCtD
Olmesartan—Syncope—Dexamethasone—psoriatic arthritis	0.000476	0.00147	CcSEcCtD
Olmesartan—Arrhythmia—Prednisone—psoriatic arthritis	0.000474	0.00147	CcSEcCtD
Olmesartan—Infection—Triamcinolone—psoriatic arthritis	0.000474	0.00147	CcSEcCtD
Olmesartan—Infection—Methylprednisolone—psoriatic arthritis	0.000473	0.00146	CcSEcCtD
Olmesartan—Haematuria—Methotrexate—psoriatic arthritis	0.000471	0.00146	CcSEcCtD
Olmesartan—Shock—Triamcinolone—psoriatic arthritis	0.00047	0.00145	CcSEcCtD
Olmesartan—Insomnia—Prednisolone—psoriatic arthritis	0.00047	0.00145	CcSEcCtD
Olmesartan—Alopecia—Prednisone—psoriatic arthritis	0.000469	0.00145	CcSEcCtD
Olmesartan—Shock—Methylprednisolone—psoriatic arthritis	0.000469	0.00145	CcSEcCtD
Olmesartan—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000467	0.00144	CcSEcCtD
Olmesartan—Loss of consciousness—Betamethasone—psoriatic arthritis	0.000467	0.00144	CcSEcCtD
Olmesartan—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.000467	0.00144	CcSEcCtD
Olmesartan—Tachycardia—Triamcinolone—psoriatic arthritis	0.000466	0.00144	CcSEcCtD
Olmesartan—Mental disorder—Prednisone—psoriatic arthritis	0.000465	0.00144	CcSEcCtD
Olmesartan—Tachycardia—Methylprednisolone—psoriatic arthritis	0.000465	0.00144	CcSEcCtD
Olmesartan—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000463	0.00143	CcSEcCtD
Olmesartan—Malnutrition—Prednisone—psoriatic arthritis	0.000462	0.00143	CcSEcCtD
Olmesartan—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.000462	0.00143	CcSEcCtD
Olmesartan—Agranulocytosis—Methotrexate—psoriatic arthritis	0.000461	0.00143	CcSEcCtD
Olmesartan—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.000461	0.00142	CcSEcCtD
Olmesartan—Myalgia—Dexamethasone—psoriatic arthritis	0.000452	0.0014	CcSEcCtD
Olmesartan—Myalgia—Betamethasone—psoriatic arthritis	0.000452	0.0014	CcSEcCtD
Olmesartan—Anxiety—Betamethasone—psoriatic arthritis	0.00045	0.00139	CcSEcCtD
Olmesartan—Anxiety—Dexamethasone—psoriatic arthritis	0.00045	0.00139	CcSEcCtD
Olmesartan—Discomfort—Dexamethasone—psoriatic arthritis	0.000447	0.00138	CcSEcCtD
Olmesartan—Discomfort—Betamethasone—psoriatic arthritis	0.000447	0.00138	CcSEcCtD
Olmesartan—Hypotension—Methylprednisolone—psoriatic arthritis	0.000445	0.00138	CcSEcCtD
Olmesartan—Pain—Prednisolone—psoriatic arthritis	0.000444	0.00137	CcSEcCtD
Olmesartan—Pharyngitis—Methotrexate—psoriatic arthritis	0.000441	0.00136	CcSEcCtD
Olmesartan—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.000438	0.00136	CcSEcCtD
Olmesartan—Vision blurred—Prednisone—psoriatic arthritis	0.000436	0.00135	CcSEcCtD
Olmesartan—Urethral disorder—Methotrexate—psoriatic arthritis	0.000435	0.00135	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000435	0.00135	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000434	0.00134	CcSEcCtD
Olmesartan—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.000433	0.00134	CcSEcCtD
Olmesartan—Oedema—Betamethasone—psoriatic arthritis	0.000433	0.00134	CcSEcCtD
Olmesartan—Oedema—Dexamethasone—psoriatic arthritis	0.000433	0.00134	CcSEcCtD
Olmesartan—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.000433	0.00134	CcSEcCtD
Olmesartan—Insomnia—Triamcinolone—psoriatic arthritis	0.000432	0.00134	CcSEcCtD
Olmesartan—Insomnia—Methylprednisolone—psoriatic arthritis	0.000431	0.00133	CcSEcCtD
Olmesartan—Infection—Dexamethasone—psoriatic arthritis	0.00043	0.00133	CcSEcCtD
Olmesartan—Infection—Betamethasone—psoriatic arthritis	0.00043	0.00133	CcSEcCtD
Olmesartan—Ill-defined disorder—Prednisone—psoriatic arthritis	0.000429	0.00133	CcSEcCtD
Olmesartan—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000428	0.00132	CcSEcCtD
Olmesartan—Anaemia—Prednisone—psoriatic arthritis	0.000427	0.00132	CcSEcCtD
Olmesartan—Shock—Dexamethasone—psoriatic arthritis	0.000426	0.00132	CcSEcCtD
Olmesartan—Shock—Betamethasone—psoriatic arthritis	0.000426	0.00132	CcSEcCtD
Olmesartan—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000425	0.00131	CcSEcCtD
Olmesartan—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000425	0.00131	CcSEcCtD
Olmesartan—Agitation—Prednisone—psoriatic arthritis	0.000425	0.00131	CcSEcCtD
Olmesartan—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.000424	0.00131	CcSEcCtD
Olmesartan—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.000424	0.00131	CcSEcCtD
Olmesartan—Tachycardia—Betamethasone—psoriatic arthritis	0.000423	0.00131	CcSEcCtD
Olmesartan—Tachycardia—Dexamethasone—psoriatic arthritis	0.000423	0.00131	CcSEcCtD
Olmesartan—Angioedema—Prednisone—psoriatic arthritis	0.000422	0.00131	CcSEcCtD
Olmesartan—Dyspepsia—Triamcinolone—psoriatic arthritis	0.00042	0.0013	CcSEcCtD
Olmesartan—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000419	0.0013	CcSEcCtD
Olmesartan—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.000419	0.0013	CcSEcCtD
Olmesartan—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.000419	0.0013	CcSEcCtD
Olmesartan—Malaise—Prednisone—psoriatic arthritis	0.000417	0.00129	CcSEcCtD
Olmesartan—Vertigo—Prednisone—psoriatic arthritis	0.000415	0.00128	CcSEcCtD
Olmesartan—Syncope—Prednisone—psoriatic arthritis	0.000415	0.00128	CcSEcCtD
Olmesartan—Anorexia—Dexamethasone—psoriatic arthritis	0.000413	0.00128	CcSEcCtD
Olmesartan—Anorexia—Betamethasone—psoriatic arthritis	0.000413	0.00128	CcSEcCtD
Olmesartan—Urticaria—Prednisolone—psoriatic arthritis	0.000413	0.00128	CcSEcCtD
Olmesartan—Fatigue—Triamcinolone—psoriatic arthritis	0.000412	0.00127	CcSEcCtD
Olmesartan—Fatigue—Methylprednisolone—psoriatic arthritis	0.000411	0.00127	CcSEcCtD
Olmesartan—Pain—Triamcinolone—psoriatic arthritis	0.000408	0.00126	CcSEcCtD
Olmesartan—Loss of consciousness—Prednisone—psoriatic arthritis	0.000406	0.00126	CcSEcCtD
Olmesartan—Hypotension—Dexamethasone—psoriatic arthritis	0.000405	0.00125	CcSEcCtD
Olmesartan—Hypotension—Betamethasone—psoriatic arthritis	0.000405	0.00125	CcSEcCtD
Olmesartan—Angiopathy—Methotrexate—psoriatic arthritis	0.000403	0.00125	CcSEcCtD
Olmesartan—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.0004	0.00124	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000395	0.00122	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000395	0.00122	CcSEcCtD
Olmesartan—Arthralgia—Prednisone—psoriatic arthritis	0.000394	0.00122	CcSEcCtD
Olmesartan—Myalgia—Prednisone—psoriatic arthritis	0.000394	0.00122	CcSEcCtD
Olmesartan—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000394	0.00122	CcSEcCtD
Olmesartan—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000393	0.00121	CcSEcCtD
Olmesartan—Anxiety—Prednisone—psoriatic arthritis	0.000392	0.00121	CcSEcCtD
Olmesartan—Alopecia—Methotrexate—psoriatic arthritis	0.000392	0.00121	CcSEcCtD
Olmesartan—Insomnia—Betamethasone—psoriatic arthritis	0.000392	0.00121	CcSEcCtD
Olmesartan—Insomnia—Dexamethasone—psoriatic arthritis	0.000392	0.00121	CcSEcCtD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000391	0.00121	CcSEcCtD
Olmesartan—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.00039	0.0012	CcSEcCtD
Olmesartan—Discomfort—Prednisone—psoriatic arthritis	0.000389	0.0012	CcSEcCtD
Olmesartan—Mental disorder—Methotrexate—psoriatic arthritis	0.000389	0.0012	CcSEcCtD
Olmesartan—Malnutrition—Methotrexate—psoriatic arthritis	0.000386	0.00119	CcSEcCtD
Olmesartan—Dyspepsia—Betamethasone—psoriatic arthritis	0.000381	0.00118	CcSEcCtD
Olmesartan—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000381	0.00118	CcSEcCtD
Olmesartan—Urticaria—Triamcinolone—psoriatic arthritis	0.000379	0.00117	CcSEcCtD
Olmesartan—Urticaria—Methylprednisolone—psoriatic arthritis	0.000379	0.00117	CcSEcCtD
Olmesartan—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000378	0.00117	CcSEcCtD
Olmesartan—Anaphylactic shock—Prednisone—psoriatic arthritis	0.000377	0.00117	CcSEcCtD
Olmesartan—Oedema—Prednisone—psoriatic arthritis	0.000377	0.00117	CcSEcCtD
Olmesartan—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000377	0.00116	CcSEcCtD
Olmesartan—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000377	0.00116	CcSEcCtD
Olmesartan—Decreased appetite—Betamethasone—psoriatic arthritis	0.000377	0.00116	CcSEcCtD
Olmesartan—Infection—Prednisone—psoriatic arthritis	0.000375	0.00116	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000374	0.00116	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000374	0.00116	CcSEcCtD
Olmesartan—Back pain—Methotrexate—psoriatic arthritis	0.000374	0.00116	CcSEcCtD
Olmesartan—Fatigue—Dexamethasone—psoriatic arthritis	0.000374	0.00116	CcSEcCtD
Olmesartan—Fatigue—Betamethasone—psoriatic arthritis	0.000374	0.00116	CcSEcCtD
Olmesartan—Shock—Prednisone—psoriatic arthritis	0.000371	0.00115	CcSEcCtD
Olmesartan—Pain—Betamethasone—psoriatic arthritis	0.000371	0.00115	CcSEcCtD
Olmesartan—Pain—Dexamethasone—psoriatic arthritis	0.000371	0.00115	CcSEcCtD
Olmesartan—Nervous system disorder—Prednisone—psoriatic arthritis	0.00037	0.00114	CcSEcCtD
Olmesartan—Tachycardia—Prednisone—psoriatic arthritis	0.000368	0.00114	CcSEcCtD
Olmesartan—Skin disorder—Prednisone—psoriatic arthritis	0.000367	0.00113	CcSEcCtD
Olmesartan—Hyperhidrosis—Prednisone—psoriatic arthritis	0.000365	0.00113	CcSEcCtD
Olmesartan—Vision blurred—Methotrexate—psoriatic arthritis	0.000364	0.00113	CcSEcCtD
Olmesartan—Anorexia—Prednisone—psoriatic arthritis	0.00036	0.00111	CcSEcCtD
Olmesartan—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.000359	0.00111	CcSEcCtD
Olmesartan—Anaemia—Methotrexate—psoriatic arthritis	0.000357	0.0011	CcSEcCtD
Olmesartan—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000357	0.0011	CcSEcCtD
Olmesartan—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000357	0.0011	CcSEcCtD
Olmesartan—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000354	0.0011	CcSEcCtD
Olmesartan—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000354	0.0011	CcSEcCtD
Olmesartan—Malaise—Methotrexate—psoriatic arthritis	0.000348	0.00108	CcSEcCtD
Olmesartan—Vertigo—Methotrexate—psoriatic arthritis	0.000347	0.00107	CcSEcCtD
Olmesartan—Leukopenia—Methotrexate—psoriatic arthritis	0.000346	0.00107	CcSEcCtD
Olmesartan—Urticaria—Dexamethasone—psoriatic arthritis	0.000344	0.00106	CcSEcCtD
Olmesartan—Urticaria—Betamethasone—psoriatic arthritis	0.000344	0.00106	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000344	0.00106	CcSEcCtD
Olmesartan—Dizziness—Prednisolone—psoriatic arthritis	0.000343	0.00106	CcSEcCtD
Olmesartan—Asthenia—Triamcinolone—psoriatic arthritis	0.000343	0.00106	CcSEcCtD
Olmesartan—Abdominal pain—Betamethasone—psoriatic arthritis	0.000343	0.00106	CcSEcCtD
Olmesartan—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000343	0.00106	CcSEcCtD
Olmesartan—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000343	0.00106	CcSEcCtD
Olmesartan—Body temperature increased—Betamethasone—psoriatic arthritis	0.000343	0.00106	CcSEcCtD
Olmesartan—Asthenia—Methylprednisolone—psoriatic arthritis	0.000342	0.00106	CcSEcCtD
Olmesartan—Insomnia—Prednisone—psoriatic arthritis	0.000341	0.00106	CcSEcCtD
Olmesartan—Pruritus—Triamcinolone—psoriatic arthritis	0.000338	0.00104	CcSEcCtD
Olmesartan—Cough—Methotrexate—psoriatic arthritis	0.000337	0.00104	CcSEcCtD
Olmesartan—Pruritus—Methylprednisolone—psoriatic arthritis	0.000337	0.00104	CcSEcCtD
Olmesartan—Dyspepsia—Prednisone—psoriatic arthritis	0.000332	0.00103	CcSEcCtD
Olmesartan—Chest pain—Methotrexate—psoriatic arthritis	0.000329	0.00102	CcSEcCtD
Olmesartan—Myalgia—Methotrexate—psoriatic arthritis	0.000329	0.00102	CcSEcCtD
Olmesartan—Arthralgia—Methotrexate—psoriatic arthritis	0.000329	0.00102	CcSEcCtD
Olmesartan—Decreased appetite—Prednisone—psoriatic arthritis	0.000328	0.00101	CcSEcCtD
Olmesartan—Rash—Prednisolone—psoriatic arthritis	0.000327	0.00101	CcSEcCtD
Olmesartan—Dermatitis—Prednisolone—psoriatic arthritis	0.000327	0.00101	CcSEcCtD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000327	0.00101	CcSEcCtD
Olmesartan—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000326	0.00101	CcSEcCtD
Olmesartan—Fatigue—Prednisone—psoriatic arthritis	0.000325	0.00101	CcSEcCtD
Olmesartan—Headache—Prednisolone—psoriatic arthritis	0.000325	0.00101	CcSEcCtD
Olmesartan—Discomfort—Methotrexate—psoriatic arthritis	0.000325	0.001	CcSEcCtD
Olmesartan—Constipation—Prednisone—psoriatic arthritis	0.000323	0.000998	CcSEcCtD
Olmesartan—Dizziness—Triamcinolone—psoriatic arthritis	0.000316	0.000976	CcSEcCtD
Olmesartan—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.000315	0.000975	CcSEcCtD
Olmesartan—Dizziness—Methylprednisolone—psoriatic arthritis	0.000315	0.000974	CcSEcCtD
Olmesartan—Infection—Methotrexate—psoriatic arthritis	0.000313	0.000969	CcSEcCtD
Olmesartan—Feeling abnormal—Prednisone—psoriatic arthritis	0.000311	0.000961	CcSEcCtD
Olmesartan—Asthenia—Dexamethasone—psoriatic arthritis	0.000311	0.000961	CcSEcCtD
Olmesartan—Asthenia—Betamethasone—psoriatic arthritis	0.000311	0.000961	CcSEcCtD
Olmesartan—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000309	0.000956	CcSEcCtD
Olmesartan—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000309	0.000955	CcSEcCtD
Olmesartan—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000309	0.000954	CcSEcCtD
Olmesartan—Nausea—Prednisolone—psoriatic arthritis	0.000308	0.000954	CcSEcCtD
Olmesartan—Pruritus—Dexamethasone—psoriatic arthritis	0.000307	0.000948	CcSEcCtD
Olmesartan—Pruritus—Betamethasone—psoriatic arthritis	0.000307	0.000948	CcSEcCtD
Olmesartan—Skin disorder—Methotrexate—psoriatic arthritis	0.000306	0.000947	CcSEcCtD
Olmesartan—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000305	0.000943	CcSEcCtD
Olmesartan—Vomiting—Triamcinolone—psoriatic arthritis	0.000304	0.000939	CcSEcCtD
Olmesartan—Vomiting—Methylprednisolone—psoriatic arthritis	0.000303	0.000937	CcSEcCtD
Olmesartan—Rash—Triamcinolone—psoriatic arthritis	0.000301	0.000931	CcSEcCtD
Olmesartan—Dermatitis—Triamcinolone—psoriatic arthritis	0.000301	0.00093	CcSEcCtD
Olmesartan—Anorexia—Methotrexate—psoriatic arthritis	0.000301	0.000929	CcSEcCtD
Olmesartan—Rash—Methylprednisolone—psoriatic arthritis	0.0003	0.000929	CcSEcCtD
Olmesartan—Dermatitis—Methylprednisolone—psoriatic arthritis	0.0003	0.000928	CcSEcCtD
Olmesartan—Urticaria—Prednisone—psoriatic arthritis	0.0003	0.000927	CcSEcCtD
Olmesartan—Headache—Triamcinolone—psoriatic arthritis	0.000299	0.000925	CcSEcCtD
Olmesartan—Headache—Methylprednisolone—psoriatic arthritis	0.000298	0.000923	CcSEcCtD
Olmesartan—Abdominal pain—Prednisone—psoriatic arthritis	0.000298	0.000922	CcSEcCtD
Olmesartan—Body temperature increased—Prednisone—psoriatic arthritis	0.000298	0.000922	CcSEcCtD
Olmesartan—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000296	0.000917	CcSEcCtD
Olmesartan—Diarrhoea—Betamethasone—psoriatic arthritis	0.000296	0.000917	CcSEcCtD
Olmesartan—Hypotension—Methotrexate—psoriatic arthritis	0.000295	0.000911	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000287	0.000888	CcSEcCtD
Olmesartan—Dizziness—Dexamethasone—psoriatic arthritis	0.000287	0.000886	CcSEcCtD
Olmesartan—Dizziness—Betamethasone—psoriatic arthritis	0.000287	0.000886	CcSEcCtD
Olmesartan—Insomnia—Methotrexate—psoriatic arthritis	0.000285	0.000882	CcSEcCtD
Olmesartan—Nausea—Triamcinolone—psoriatic arthritis	0.000284	0.000877	CcSEcCtD
Olmesartan—Nausea—Methylprednisolone—psoriatic arthritis	0.000283	0.000875	CcSEcCtD
Olmesartan—Dyspepsia—Methotrexate—psoriatic arthritis	0.000278	0.000858	CcSEcCtD
Olmesartan—Vomiting—Betamethasone—psoriatic arthritis	0.000275	0.000852	CcSEcCtD
Olmesartan—Vomiting—Dexamethasone—psoriatic arthritis	0.000275	0.000852	CcSEcCtD
Olmesartan—Decreased appetite—Methotrexate—psoriatic arthritis	0.000274	0.000848	CcSEcCtD
Olmesartan—Rash—Betamethasone—psoriatic arthritis	0.000273	0.000845	CcSEcCtD
Olmesartan—Rash—Dexamethasone—psoriatic arthritis	0.000273	0.000845	CcSEcCtD
Olmesartan—Dermatitis—Dexamethasone—psoriatic arthritis	0.000273	0.000844	CcSEcCtD
Olmesartan—Dermatitis—Betamethasone—psoriatic arthritis	0.000273	0.000844	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000272	0.000842	CcSEcCtD
Olmesartan—Fatigue—Methotrexate—psoriatic arthritis	0.000272	0.000841	CcSEcCtD
Olmesartan—Headache—Dexamethasone—psoriatic arthritis	0.000271	0.000839	CcSEcCtD
Olmesartan—Headache—Betamethasone—psoriatic arthritis	0.000271	0.000839	CcSEcCtD
Olmesartan—Asthenia—Prednisone—psoriatic arthritis	0.000271	0.000837	CcSEcCtD
Olmesartan—Pain—Methotrexate—psoriatic arthritis	0.00027	0.000834	CcSEcCtD
Olmesartan—Pruritus—Prednisone—psoriatic arthritis	0.000267	0.000825	CcSEcCtD
Olmesartan—Feeling abnormal—Methotrexate—psoriatic arthritis	0.00026	0.000804	CcSEcCtD
Olmesartan—Diarrhoea—Prednisone—psoriatic arthritis	0.000258	0.000798	CcSEcCtD
Olmesartan—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000258	0.000797	CcSEcCtD
Olmesartan—Nausea—Betamethasone—psoriatic arthritis	0.000257	0.000796	CcSEcCtD
Olmesartan—Nausea—Dexamethasone—psoriatic arthritis	0.000257	0.000796	CcSEcCtD
Olmesartan—Urticaria—Methotrexate—psoriatic arthritis	0.000251	0.000775	CcSEcCtD
Olmesartan—Dizziness—Prednisone—psoriatic arthritis	0.00025	0.000772	CcSEcCtD
Olmesartan—Abdominal pain—Methotrexate—psoriatic arthritis	0.000249	0.000771	CcSEcCtD
Olmesartan—Body temperature increased—Methotrexate—psoriatic arthritis	0.000249	0.000771	CcSEcCtD
Olmesartan—Vomiting—Prednisone—psoriatic arthritis	0.00024	0.000742	CcSEcCtD
Olmesartan—Rash—Prednisone—psoriatic arthritis	0.000238	0.000736	CcSEcCtD
Olmesartan—Dermatitis—Prednisone—psoriatic arthritis	0.000238	0.000735	CcSEcCtD
Olmesartan—Headache—Prednisone—psoriatic arthritis	0.000236	0.000731	CcSEcCtD
Olmesartan—Asthenia—Methotrexate—psoriatic arthritis	0.000226	0.0007	CcSEcCtD
Olmesartan—Nausea—Prednisone—psoriatic arthritis	0.000224	0.000693	CcSEcCtD
Olmesartan—Pruritus—Methotrexate—psoriatic arthritis	0.000223	0.00069	CcSEcCtD
Olmesartan—Diarrhoea—Methotrexate—psoriatic arthritis	0.000216	0.000667	CcSEcCtD
Olmesartan—Dizziness—Methotrexate—psoriatic arthritis	0.000209	0.000645	CcSEcCtD
Olmesartan—Vomiting—Methotrexate—psoriatic arthritis	0.000201	0.00062	CcSEcCtD
Olmesartan—Rash—Methotrexate—psoriatic arthritis	0.000199	0.000615	CcSEcCtD
Olmesartan—Dermatitis—Methotrexate—psoriatic arthritis	0.000199	0.000614	CcSEcCtD
Olmesartan—Headache—Methotrexate—psoriatic arthritis	0.000198	0.000611	CcSEcCtD
Olmesartan—Nausea—Methotrexate—psoriatic arthritis	0.000187	0.000579	CcSEcCtD
